ISSUE
posterior segment • innovation • enlightenment
2 09 | 11 | 21
PIE M A G A ZINE ’ S D A ILY CONGR E S S NE W S ON T HE P O S T E RIOR S E GME N T
HIGHLIGHTS out the 04 Check universal guidelines
for the management of DME
the 08 Behold vitreoretinal surgeons’ nightmares!
Eyes — How 11 Fragile ophthalmologists
treat eye diseases in premature babies
Published by
Matt Young
EURETINA Eyes AI Artificial intelligence takes center stage at this year’s conference
CEO & Publisher
Hannah Nguyen COO & CFO
Robert Anderson Media Director
Gloria D. Gamat Chief Editor
Mapet L. Poso Editor
Brandon Winkeler International Business Development Graphic Designers
Maricel Salvador Kelsey Roode Writers
Elisa DeMartino Hazlin Hassan Nick Eustice Olawale Salami Tan Sher Lynn Media MICE Pte. Ltd.
6001 Beach Road, #19-06 Golden Mile Tower, Singapore 199589 Tel. Nos.: +65 8186 7677 | +1 302 261 5379 Email: enquiry@mediamice.com www.mediaMICE.com
piemagazine.org
by Nick Eustice
T
he 8th session in this year’s EURETINA virtual conference has, in the words of its co-chair, Dr. Ursula Schmidt-Erfurth, become something of a good tradition, as it represents the guidelines for the future of managing retinal diseases. Each year, this forum focuses on new technologies and methodologies being applied in retinal treatments, in what it terms “The Next Steps”.
Taking the next steps with AI This year, the forum is dedicated to discussing one of the biggest terms being heard all around the conference: artificial intelligence (AI). AI is playing an ever-growing role in how retinal conditions are being identified, tracked, and diagnosed, and it makes perfect sense that it takes center stage in the discussion of the next steps forward. “We always claimed that this is about the next steps, and it always is,” said Dr. Schmidt-
Erfurth. “So this year, we do have a focus on artificial intelligence, which is not only a next step, but also a horizon.” For, indeed, though the nascent applications of AI are already teaching us things about disease progressions that have never been detectable in the past, we are still at the very beginning of exploring its applications.
AI in AMD Treatment — What’s New? One of the areas in which AI has been of such tremendous benefit is its use in the analysis of color fundus photographs (CFP). Beginning the discussion of this topic, Dr. Caroline Klaver presented the ways in which AI-assisted CFP is useful in treating age-related macular degeneration (AMD). There are two primary levels in which this technology has begun to make an impact here. >> continued on Page 3